UBS AM’s Avalyn Pharma AVLN Stock Holding History
Bought
Maintained
Sold
Other funds holding AVLN
UBS AM's AVLN Position: Q3 2026 in Review
UBS AM opened a new position in Avalyn Pharma (AVLN) in Q3 2026: 108 shares worth $3.08K. The stake represents ﹤0.01% of the portfolio and ranks #3983 among its holdings.
86 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.
- UBS AM held 108 shares of Avalyn Pharma worth $3.08K as of Q3 2026.
- Avalyn Pharma was a new UBS AM position in Q3 2026.
- Avalyn Pharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3983 holding.
- 86 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.